←
RareCyte, Inc.969 posts
RareCyte, Inc. avatar

RareCyte, Inc.

@RareCyte

High-confidence spatial biology and liquid biopsy

◷ Joined July 2016▧ 565 Photos and videos
RareCyte, Inc. avatar
RareCyte, Inc.@RareCyte·Oct 29

How can spatial proteomics help uncover biomarkers of immunotherapy response and resistance? At #SITC2026, Jeremiah Wala, MD, PhD, of Dana-Farber Cancer Institute will share findings from a phase 1/2 clinical trial of copanlisib plus nivolumab in colorectal cancer.

Post attachment
RareCyte, Inc. avatar
RareCyte, Inc.@RareCyte·Oct 28

Join us on November 18 for a webinar featuring William Mifsud, PhD, Head of Pathology Research at Kite Pharma, as he shares how his team uses Orion™ multiplex immunofluorescence to assess combinatorial target expression across large tissue cohorts. fiercepharma.com/premium/web…

Post attachment
RareCyte, Inc. avatar
RareCyte, Inc.@RareCyte·Oct 19

How well do circulating tumor cells (CTCs) reflect the biology of a patient’s tumor? 🤔 A new study from UW provides compelling evidence that CTC protein expression can reflect key tumor characteristics in patients with advanced prostate cancer. onlinelibrary.wiley.com/doi/…

Post attachment
RareCyte, Inc. avatar
RareCyte, Inc.@RareCyte·Sep 30

Learn how to translate your research question into a custom spatial biomarker panel. Next week, join a short webinar focused on designing panels for the Orion™ spatial proteomics platform. ✅ See a live demo of the new Panel Designer tool 👉 Register: rarecyte.com/webinar-2026.10…

Post attachment
RareCyte, Inc. avatar
RareCyte, Inc.@RareCyte·Sep 17

Join us for a 30-minute live session focused on how to translate a biological research question into a custom spatial biomarker panel on the Orion spatial proteomics platform. Plus, see a demo of the new Orion Panel Designer tool. Register here: rarecyte.com/webinar-2026.10…

Post attachment